News Archive

A DCRI study stratified patients based on their exercise ECG and stress echo results and examined patient outcomes to determine whether discordant results could be used as an indicator for higher risk of adverse outcomes.

Neither prescription volume nor approval rates for PCSK9 inhibitors increased following the release of results from two large outcomes trials that demonstrated safety and effectiveness of this nove

In a recent editorial, DCRI faculty call for improved heart failure trial enrollment, as well as modifications to the infrastructure used to evaluate whether treatments work in real-world settings.

Two DCRI researchers contributed to a study that points to a potential early warning sign for increased risk of cardiovascular disease.

Despite gaps in resuscitation care between patients on dialysis and patients not receiving dialysis, study results showed similar survival rates for both groups.

The study found that a video game-based treatment was effective both for children receiving ADHD medication along with the digital therapeutic and for children receiving only the digital therapeutic.

The EXSCEL trial, which explored the impact of exenatide on major cardiovascular events in patients with Type 2 diabetes, has also published nearly a dozen secondary manuscripts on a range of topic

In response to a recent study that found the majority of cardiovascular patients are eligible for at least one of 12 novel secondary prevention therapies, representatives from the DCRI urge a focus

The observational study found that amongst acute ischemic stroke patients treated with intravenous tissue plasminogen activator, patients who had experienced a previous stroke within the past two w

The HARMONEE trial is part of the Harmonization by Doing program, which aims to create a uniform pathway for clinical development in the U.S. and Japan.